Literature DB >> 2525108

Life tables for Down syndrome.

P A Baird1, A D Sadovnick.   

Abstract

Life expectancy in Down syndrome was calculated to 68 years, using data for 1610 Down syndrome liveborn individuals among over 1.5 million consecutive British Columbia livebirths. Overall, although survival is significantly poorer than for the general population, over half of Down syndrome individuals can be expected to survive into their fifties, and 13.5% will still be alive at age 68. The data are presented as a life table, a practical format for the clinician and planner.

Entities:  

Mesh:

Year:  1989        PMID: 2525108     DOI: 10.1007/bf00291175

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  3 in total

1.  Measuring birth defects and handicapping disorders in the population: the British Columbia Health Surveillance Registry.

Authors:  P A Baird
Journal:  CMAJ       Date:  1987-01-15       Impact factor: 8.262

2.  Life expectancy in Down syndrome adults.

Authors:  P A Baird; A D Sadovnick
Journal:  Lancet       Date:  1988-12-10       Impact factor: 79.321

3.  Life expectancy in Down syndrome.

Authors:  P A Baird; A D Sadovnick
Journal:  J Pediatr       Date:  1987-06       Impact factor: 4.406

  3 in total
  13 in total

1.  Anesthetic Management of a Down Syndrome Patient with Subocclusive Syndrome.

Authors:  George Gabriel Moldoveanu; Emilia Severin; Andreea Paun
Journal:  Maedica (Buchar)       Date:  2018-06

2.  Renal involvement in Down syndrome.

Authors:  Serafín Málaga; Rafael Pardo; Ignacio Málaga; Gonzalo Orejas; Joaquín Fernández-Toral
Journal:  Pediatr Nephrol       Date:  2005-03-23       Impact factor: 3.714

Review 3.  Aspects of digestive tract tumors in Down syndrome: a literature review.

Authors:  Daniel Satgé; Annie J Sasco; Michel J J Vekemans; Marie-Laure Portal; Jean-François Fléjou
Journal:  Dig Dis Sci       Date:  2006-09-29       Impact factor: 3.199

4.  Differential effects of Epigallocatechin-3-gallate containing supplements on correcting skeletal defects in a Down syndrome mouse model.

Authors:  Irushi Abeysekera; Jared Thomas; Taxiarchis M Georgiadis; Alycia G Berman; Max A Hammond; Karl J Dria; Joseph M Wallace; Randall J Roper
Journal:  Mol Nutr Food Res       Date:  2016-02-11       Impact factor: 5.914

5.  Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.

Authors:  P T Dick
Journal:  CMAJ       Date:  1996-02-15       Impact factor: 8.262

6.  Social conditions for people with Down syndrome: a register-based cohort study in Denmark.

Authors:  Jin Liang Zhu; Carsten Obel; Henrik Hasle; Sonja A Rasmussen; Jiong Li; Jørn Olsen
Journal:  Am J Med Genet A       Date:  2013-11-22       Impact factor: 2.802

7.  Bilateral femoral neck fractures resulting from a grand mal seizure in an elderly man with Down syndrome.

Authors:  Jonathan P Marsh; Jeff R S Leiter; Peter Macdonald
Journal:  Orthop Rev (Pavia)       Date:  2010-03-20

Review 8.  Current Analysis of Skeletal Phenotypes in Down Syndrome.

Authors:  Jared R Thomas; Randall J Roper
Journal:  Curr Osteoporos Rep       Date:  2021-04-08       Impact factor: 5.163

9.  An estimate of the heritable fraction of childhood cancer.

Authors:  S A Narod; C Stiller; G M Lenoir
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

Review 10.  Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.

Authors:  Tomer Illouz; Arya Biragyn; Maria Florencia Iulita; Lisi Flores-Aguilar; Mara Dierssen; Ilario De Toma; Stylianos E Antonarakis; Eugene Yu; Yann Herault; Marie-Claude Potier; Alexandra Botté; Randall Roper; Benjamin Sredni; Jacqueline London; William Mobley; Andre Strydom; Eitan Okun
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.